Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization

References

• El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology200713272557257617570226
   PubMed Web of Science ®Google Scholar
• YounossiZMOtgonsurenMHenryLAssociation of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009Hepatology20156261723173026274335
   PubMed Web of Science ®Google Scholar
• LauWYLaiECLeungTWYuSCAdjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survivalAnn Surg20082471434818156922
   PubMed Web of Science ®Google Scholar
• TournouxCPaolettiXBarbareJCTreatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapiesCancer Treat Rev200733876276317643827
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• WangZRenZChenYAdjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled studyClin Cancer Res20182492074208129420221
   PubMed Web of Science ®Google Scholar
• JiangJHGuoZLuHFAdjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysisWorld J Gastroenterol201521154627463425914472
   PubMed Web of Science ®Google Scholar
• PaikKYKimEKPathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resectionHepatobiliary Pancreat Dis Int201615215816427020632
   PubMedGoogle Scholar
• BruixJQinSMerlePRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet201738910064566627932229
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• TsurusakiMMurakamiTSurgical and locoregional therapy of HCC: TACELiver Cancer20154316517526675172
   PubMed Web of Science ®Google Scholar
• BagshawPFAllardyceRAFramptonCMLong-term outcomes of the Australasian randomized clinical trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian Laparoscopic Colon Cancer Study trialAnn Surg2012256691591923154392
   PubMed Web of Science ®Google Scholar
• JayneDGThorpeHCCopelandJQuirkePBrownJMGuillouPJFive-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancerBr J Surg201097111638164520629110
   PubMed Web of Science ®Google Scholar
• WuCYLinJTHoHJAssociation of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort studyGastroenterology20141471e145143151
   Web of Science ®Google Scholar
• HannHWWanSLaiYAspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infectionJ Gastroenterol Hepatol201530113113824995497
   PubMed Web of Science ®Google Scholar
• SuCWChauGYHungHHImpact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resectionAnn Surg Oncol20152272253226125490872
   PubMed Web of Science ®Google Scholar
• HuHChenGFYuanWWangJHZhaiBMicrowave ablation with chemoembolization for large hepatocellular carcinoma in patients with cirrhosisInt J Hyperthermia20183481351135829720001
   PubMed Web of Science ®Google Scholar
• LinCLKaoJHReview article: the prevention of hepatitis B-related hepatocellular carcinomaAliment Pharmacol Ther201848151429722445
   PubMed Web of Science ®Google Scholar
• PersicoMAglittiAAghemoAHigh efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinomaAliment Pharmacol Ther201847121705171229722439
   PubMed Web of Science ®Google Scholar
• IshizukaMKubotaKKitaJShimodaMKatoMSawadaTImpact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patientsAm J Surg2012203110110621429472
   PubMed Web of Science ®Google Scholar
• ManoYShirabeKYamashitaYPreoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysisAnn Surg2013258230130523774313
   PubMed Web of Science ®Google Scholar
• MurrayKFCarithersRLJrAASLDAASLD practice guidelines: evaluation of the patient for liver transplantationHepatology20054161407143215880505
   PubMed Web of Science ®Google Scholar
• ShenSLFuSJChenBPreoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resectionAnn Surg Oncol201421123802380924849520
   PubMed Web of Science ®Google Scholar
• CampRLDolled-FilhartMRimmDLX-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimizationClin Cancer Res200410217252725915534099
   PubMed Web of Science ®Google Scholar
• IasonosASchragDRajGVPanageasKSHow to build and interpret a nomogram for cancer prognosisJ Clin Oncol20082681364137018323559
   PubMed Web of Science ®Google Scholar
• SchütteKTippeltBSchulzCMalnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC)Clin Nutr20153461122112725434576
   PubMed Web of Science ®Google Scholar
• BoursierJBrochardCBertraisSCombination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis CAliment Pharmacol Ther201440217818824889599
   PubMed Web of Science ®Google Scholar
• KaoWYChiouYYHungHHRisk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio indexEur J Gastroenterol Hepatol201123652853621537128
   PubMed Web of Science ®Google Scholar
• MaJJiangYGongGEvaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infectionEur J Gastroenterol Hepatol201325442843423358121
   PubMed Web of Science ®Google Scholar
• TangTQiuJLLiGWAspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patientsClin Radiol201873325926529032942
   PubMed Web of Science ®Google Scholar
• PengBGHeQLiJPZhouFAdjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombusAm J Surg2009198331331819285298
   PubMed Web of Science ®Google Scholar